Lately, we are inundated with negative reports and information surrounding the Coronavirus outbreak.

Fortunately, there is some good news for people with type 1 diabetes. Eli Lilly announced that beginning April 6, 2020, and for $35.00 dollars a month regardless of having a health insurance plan or not having health insurance at all, people with diabetes will have access to a monthly supply of insulin. The company says it covers most of its insulins including Humalog, emphasizing that they do not anticipate shortages.

The program is called the Lilly Insulin Value Program. Mike Mason, President of  Eli Lilly Diabetes said: “too many people in the USA have lost jobs because of the COVID-19 crisis, and we want to make sure no one goes without their Lilly insulin.” People with type 1 diabetes can sign up by calling the Lilly Diabetes Solution Center at 833-808-1234, Monday through Friday from 8 am. to 8 pm. Eastern time. According to Eli Lilly Company, there is no paperwork involved, and the average time on the telephone with an Eli Lilly representative to sign up is 10 minutes. Patients can receive their cards through email or US Mail.

The copay cards are not available for people with government insurance such as Medicaid, Medicare, Medicare Part D, Tricare, Medigap or any state patient or pharmaceutical assistance program.

There are low-cost alternatives for everybody, such as free insulin for those with minimal income or insulin that is donated to other nonprofits. 

While the coronavirus pandemic has wreaked havoc upon the world and caused tremendous loss of life, fear, hospitalizations, sickness, and altered completely our way of life, a silver lining appears, this tragedy has become the catalyst for Eli Lilly to develop a program to finally make insulin more affordable and put pressure on other manufacturers, after many years of out of control price increases for insulin that has forced people to ration their medications and feed dangerous decisions on their diabetes treatments.   

Read the official press release here: 

New $35 Co-Pay Now Available Through Lilly Insulin Value Program in Response to COVID-19 Crisis in U.S.